Search for: "Grant v. Schering Corp."
Results 41 - 60
of 78
Sorted by Relevance
|
Sort by Date
31 Aug 2010, 10:01 pm
– state of research and development of new drugs in Indian pharma industry (Spicy IP) US: The Financial Times’ take on gene patenting (Patent Docs) US: Seattle Biotech companies fight over allegedly similar names: Mirina Corp. v. [read post]
17 Feb 2012, 11:29 am
Schering-Plough Corp., 842 A.2d 174, 177-78 (N.J. [read post]
13 Mar 2011, 1:50 pm
FMC Corp., 569 F.3d 1335, 1349-50 (Fed. [read post]
22 Feb 2012, 5:49 pm
” Depending on who you ask, Bayer Schering Pharma AG v. [read post]
17 Jun 2010, 6:47 am
Jirak v. [read post]
30 Jul 2009, 7:02 am
"I am not granting summary judgment on anything else," Keenan said. [read post]
9 Nov 2015, 4:00 am
This has been described by the Supreme Court of Canada in Whirlpool Corp v. [read post]
19 Sep 2013, 9:53 am
Pfizer, Inc., 712 F.3d 51 (1st Cir. 2013), and Harden Manufacturing Corp. v. [read post]
5 Jun 2013, 5:29 am
Everest Minerals Corp., 362 F. [read post]
11 Apr 2011, 7:15 pm
See Schering Corp. v. [read post]
3 Jul 2008, 7:26 pm
Baxter Healthcare Corp., 794 F. [read post]
25 Jun 2009, 4:29 am
P. 8, first in Bell Atlantic Corp. v. [read post]
24 Dec 2009, 11:32 am
Blunt v. [read post]
3 Oct 2011, 12:39 pm
LLC v. [read post]
30 Apr 2012, 7:54 pm
Geneva Pharms., Inc., 344 F.3d 1294, 1303 (11th Cir. 2003), Schering-Plough Corp. v. [read post]
1 Oct 2009, 2:14 am
Apotex Corp., 2008 WL 2047979 (S.D. [read post]
28 Jun 2007, 10:16 am
Schering-Plough Corp., 842 A.2d 174, 178 (N.J. [read post]
29 Aug 2012, 10:09 pm
Although several Circuit Court decisions have used the so-called “scope of the patent test” when considering whether patent settlement agreements violate the antitrust laws, including the Eleventh Circuit in litigation involving the same K-DUR patent settlement agreement (see Schering-Plough Corp. v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
25 Apr 2015, 11:03 am
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
